Noel R, Hammand TA, Juhaeri J, Hauber B. Weighing the benefits & risks: the science and methods of benefit-risk assessment in drug development. Presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2019. Philadelphia, PA. Previously presented at the 34th Annual ICPE Conference.

Benefit-risk assessment is now a fundamental science for understanding and evaluating the development, approval, and continued marketing of drugs and devices. This course is aimed at introducing attendees to core concepts and tools of both the science and practice of benefit-risk assessment.

Share on: